Does combining photodynamic therapy with ranibizumab improve visual acuity and reduce injections compared to ranibizumab alone in polypoidal choroidal vasculopathy?

We analyzed one assertion on this topic and found it supports the idea that combining photodynamic therapy with ranibizumab may lead to better visual outcomes and fewer injections in people with polypoidal choroidal vasculopathy who haven’t had prior treatment [1]. The evidence we’ve reviewed...